Recombinant Growth

Recombinant Growth
Author :
Publisher :
Total Pages : 38
Release :
ISBN-10 : STANFORD:36105021001024
ISBN-13 :
Rating : 4/5 ( Downloads)
DOWNLOAD EBOOK
Book Synopsis Recombinant Growth by : Martin L. Weitzman

Download or read book Recombinant Growth written by Martin L. Weitzman and published by . This book was released on 1996 with total page 38 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Recombinant Growth Related Books

Recombinant Growth
Language: en
Pages: 38

Recombinant Growth

Authors: Martin L. Weitzman
Categories: Economic development
Type: BOOK - Published: 1996 - Publisher:

DOWNLOAD EBOOK

Growth Hormone Deficiency in Adults
Language: en
Pages: 241

Growth Hormone Deficiency in Adults

Authors: Jens O. L. Jørgensen
Categories: Science
Type: BOOK - Published: 2005-01-01 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

It has been known for over 40 years that GH-deficient-children benefit from replacement with the hormone. But GH, essential for longitudinal growth, also plays
Biotechnology in Growth Regulation
Language: en
Pages: 297

Biotechnology in Growth Regulation

Authors: R.B. Heap
Categories: Science
Type: BOOK - Published: 2013-10-22 - Publisher: Butterworth-Heinemann

DOWNLOAD EBOOK

Biotechnology in Growth Regulation focuses on mechanisms of action of growth hormones and how immunological and transgenic procedures can affect growth response
Growth Hormone in Adults
Language: en
Pages: 536

Growth Hormone in Adults

Authors: Anders Juul
Categories: Medical
Type: BOOK - Published: 2000-04-27 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

This revised new edition reviews the substantial advances in our understanding of the vital role of growth hormone (GH) in maintaining adult health, and the res
Science and Social Context
Language: en
Pages: 222

Science and Social Context

Authors: Lisa N. Mills
Categories: Science
Type: BOOK - Published: 2002-05-28 - Publisher: McGill-Queen's Press - MQUP

DOWNLOAD EBOOK

She examines the decision-making processes at Monsanto that led to their making the drug available and discusses corporate, academic, and regulatory decision-ma